Stock Market & Financial Investment News

News Breaks January 2, 2013 07:56 EDT ABT, ABBV Abbott completes separation of research-based pharmaceutical business Abbott (ABT) announced it has completed the separation of its research-based pharmaceuticals business, which became AbbVie (ABBV), a new independent biopharmaceutical company. AbbVie will begin trading independently on the New York Stock Exchange today under the symbol "ABBV." News For ABT;ABBV From The Last 14 Days Check below for free stories on ABT;ABBV the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 05:15 EDT ABBV Galapagos, AbbVie extend GLPG0634 collaboration Galapagos and AbbVie announced an extension of their GLPG0634 clinical development collaboration to include Crohn's disease. Galapagos will fund and complete a Phase 2 program in Crohn's disease, which is designed to facilitate rapid progression into Phase 3. Upon successful completion of the study, expected in Q2 of 2015, AbbVie will pay Galapagos $50M. The terms of the collaboration extension are in addition to previously agreed upon financial terms. AbbVie will be responsible for funding and performing clinical development beyond Phase 2, and completing regulatory and commercialization activities. Galapagos will start an 20-week, Phase 2A/B study with GLPG0634 in 180 patients suffering from Crohn's disease by early 2014. May 16, 2013 08:55 EDT ABBV BofA/Merrill's pharmaceuticals analysts hold analyst/industry conference call Subscribe for More Information May 15, 2013 17:26 EDT ABBV Third Point gives quarterly update on stakes NEW STAKES: Virgin Media (VMED), Tiffany (TIF), B/E Aerospace (BEAV), Anadarko (APC), and Thermo Fisher (TMO). INCREASED STAKES: International Paper (IP), Abbvie (ABBV), TransDigm (TDG), Constellation Brands (STZ), and Dollar General (DG). DECREASED STAKES: Delphi (DLPH), Murphy Oil (MUR), AIG (AIG), LyondellBasell (LYB), and Liberty Global (LBTYA). LIQUIDATED STAKES: Tesoro (TSO), Morgan Stanley (MS), Symantec (SYMC), Herbalife (HLF), and Illumina (ILMN). 10:13 EDT ABBV On The Fly: Analyst Initiation Summary Subscribe for More Information 07:59 EDT ABBV AbbVie initiated with an Outperform at Cowen Subscribe for More Information May 14, 2013 10:20 EDT ABBV AbbVie volatility at 22 into ASCO Subscribe for More Information 09:27 EDT ABBV AbbVie and Alvine Pharmaceutical enter into collaboration Subscribe for More Information 07:24 EDT ABBV EBD Group to host a conference BioTrinity 2013 is being held in Newbury, England on May 14-16. May 10, 2013 16:34 EDT ABBV AbbVie chief scientific officer Leonard to retire AbbVie disclosed in a regulatory filing that John Leonard, senior VP, chief scientific officer, has informed the company that he will be retiring from the company in the next few months and will be involved in the transition process for naming his successor. May 9, 2013 07:04 EDT ABT Abbott announces CE Mark for A1c test Subscribe for More Information May 6, 2013 12:35 EDT ABT Abbott management to meet with Jefferies Subscribe for More Information 09:30 EDT ABBV Enanta says AbbVie's DAA regimen designated as breakthrough therapy designation Subscribe for More Information 09:02 EDT ABBV AbbVie investigational HCV receives breakthrough therapy designation from FDA Subscribe for More Information 07:34 EDT ABT Conference Forum to host a summit Subscribe for More Information 07:18 EDT ABT, ABBV American Congress of Obstetrics and Gynecology to hold annual meeting Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.